Gene-scan method for the recognition of carriers and patients with p47phox-deficient autosomal recessive chronic granulomatous disease

被引:51
|
作者
Dekker, J
de Boer, M
Roos, D
机构
[1] Univ Amsterdam, Dept Expt Immunohematol, Acad Med Ctr, Cent Lab Netherlands Blood Transfus Serv,CLB, NL-1066 CX Amsterdam, Netherlands
[2] Univ Amsterdam, Expt & Clin Immunol Lab, Acad Med Ctr, NL-1066 CX Amsterdam, Netherlands
关键词
D O I
10.1016/S0301-472X(01)00731-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. We devised a method to recognize carriers and patients with p47(phox)-deficient chronic granulomatous disease (A47 CGD), the most common autosomal form of the disease. CGD is characterized by the inability of phagocytic leukocytes to kill microorganisms, due to a defective NADPH oxidase system. The predominant genetic defect leading to p47(phox)-deficient CGD is a GT deletion at the beginning of exon 2 in the p47(phox) gene NCF1, most likely caused by recombination events between the NCF1 and one of its pseudogenes. It is hardly possible to investigate sequences of patients, carriers, and normal individuals using standard PCR/sequencing techniques, due to greater than 99% homology between NCF1 and its pseudogenes. Methods. In our gene-scan method, a 198-bp region of genomic DNA around exon 2 of NCF1 is amplified by nonspecific PCR with one fluorochrome-labeled primer. The mixture of NCF1 and pseudogene product, which differs by two nucleotides in length, is separated according to size. The ratio between the peak heights indicates the relative number of NCF1 genes and pseudogenes within an individual's genome. Results. The method is highly reproducible (SD = 4%) and sensitive (r = 0.998). Of the 16 healthy individuals, 15 had a 2:4 ratio (2 genes, 4 pseudogenes), 10/12 A47 CGD carriers had a 1:5 ratio, and 34 patients had only pseudogenes. In addition, gene-scans including a 20-bp duplication in intron 2 of the pseudogenes revealed insight in the crossing-over events between NCF1 and pseudogenes. Conclusions. Our method distinguishes individuals with one NCF1 gene (carriers) from controls and from NCF1-deficient patients. (C) 2001 International Society for Experimental Hematology. Published by Elsevier Science Inc.
引用
收藏
页码:1319 / 1325
页数:7
相关论文
共 50 条
  • [1] Lentiviral SIN-vector for p47phox-deficient Chronic Granulomatous Disease Gene Therapy
    Valencia, R.
    Wrona, D.
    Brendel, C.
    Haenseler, W.
    Santilli, G.
    Thrasher, A.
    Grez, M.
    Reichenbach, J.
    Siler, U.
    HUMAN GENE THERAPY, 2015, 26 (10) : A61 - A62
  • [2] Gene-edited pseudogene resurrection corrects p47phox-deficient chronic granulomatous disease
    Merling, Randall K.
    Kuhns, Douglas B.
    Sweeney, Colin L.
    Wu, Xiaolin
    Burkett, Sandra
    Chu, Jessica
    Lee, Janet
    Koontz, Sherry
    Di Pasquale, Giovanni
    Afione, Sandra A.
    Chiorini, John A.
    Kang, Elizabeth M.
    Choi, Uimook
    De Ravin, Suk See
    Malech, Harry L.
    BLOOD ADVANCES, 2017, 1 (04) : 270 - 278
  • [3] Preclinical Optimization and Safety Studies of a New Lentiviral Gene Therapy for p47phox-Deficient Chronic Granulomatous Disease
    Schejtman, Andrea
    Vetharoy, Winston
    Choi, Uimook
    Rivat, Christine
    Theobald, Narda
    Piras, Giuseppa
    Leon-Rico, Diego
    Buckland, Karen
    Armenteros-Monterroso, Elena
    Benedetti, Sara
    Ashworth, Michael T.
    Rothe, Michael
    Schambach, Axel
    Gaspar, Hubert Bobby
    Kang, Elizabeth M.
    Malech, Harry L.
    Thrasher, Adrian J.
    Santilli, Giorgia
    HUMAN GENE THERAPY, 2021, 32 (17-18) : 949 - 958
  • [4] Novel Diagnostic Tool for p47phox-Deficient Chronic Granulomatous Disease Patient and Carrier Detection
    Wrona, Dominik
    Siler, Ulrich
    Reichenbach, Janine
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 : 274 - 278
  • [5] Disseminated Tuberculosis in a Patient with Autosomal Recessive p47phox Chronic Granulomatous Disease
    Ximena León-Lara
    Alejandro Campos-Murguía
    Pablo León-Cabral
    Andrea Tello-Mercado
    Noel Salgado-Nesme
    Jesús Delgado de la Mora
    Stéphanie Boisson- Dupuis
    Jacinta Bustamante
    Lizbeth Blancas-Galicia
    Journal of Clinical Immunology, 2021, 41 : 1417 - 1419
  • [6] Disseminated Tuberculosis in a Patient with Autosomal Recessive p47phox Chronic Granulomatous Disease
    Leon-Lara, Ximena
    Campos-Murguia, Alejandro
    Leon-Cabral, Pablo
    Tello-Mercado, Andrea
    Salgado-Nesme, Noel
    de la Mora, Jesus Delgado
    Dupuis, Stephanie Boisson-
    Bustamante, Jacinta
    Blancas-Galicia, Lizbeth
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (06) : 1417 - 1419
  • [7] Lentiviral Gene Therapy for p47phox Deficient Chronic Granulomatous Disease
    Shejtman, Andrea
    Aragao Filho, Walmir Cutrim
    Weisser, Maren
    Zinicola, Marta
    Booth, Claire
    Burns, Siobhan O.
    Siler, Ulrich
    Reichenbach, Janine
    Gaspar, H. Bobby
    Neto, Antonio Condino
    Thrasher, Adrian J.
    Santilli, Giorgia
    MOLECULAR THERAPY, 2017, 25 (05) : 88 - 89
  • [8] Clinical and molecular characterization of autosomal recessive chronic granulomatous disease caused by p47-phox deficiency
    De Cornejo, M
    López, JA
    Navarro, S
    de Garcia, D
    Patiño, PJ
    REVISTA MEDICA DE CHILE, 2000, 128 (05) : 491 - 498
  • [9] CRISPR/Cas9-generated p47phox-deficient cell line for Chronic Granulomatous Disease gene therapy vector development
    Wrona, Dominik
    Siler, Ulrich
    Reichenbach, Janine
    SCIENTIFIC REPORTS, 2017, 7
  • [10] CRISPR/Cas9-generated p47phox-deficient cell line for Chronic Granulomatous Disease gene therapy vector development
    Dominik Wrona
    Ulrich Siler
    Janine Reichenbach
    Scientific Reports, 7